Results 241 to 250 of about 7,524,867 (293)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Commercialization of the Xalkori Pediatric Multiparticulate Product Using Quality-by-Design Principles. [PDF]

open access: yesPharmaceutics
Bartlett J   +5 more
europepmc   +1 more source

Quality by design for mRNA platform purification based on continuous oligo-dT chromatography. [PDF]

open access: yesMol Ther Nucleic Acids
Qu J   +9 more
europepmc   +1 more source

Quality by Design

Asian Journal of Research in Pharmaceutical Science, 2016
Quality by design (QbD) is an essential part of the modern advance to pharmaceutical quality. QbD is best key to build a quality in all pharmaceutical products. Under this concepts of be throughout design and growth of product, it is important to identify desire product performance report [Target product profile (TPP), Quality Target product profile ...
Sushila D. Chavan   +3 more
openaire   +2 more sources

Quality by design for biopharmaceuticals

Nature Biotechnology, 2009
The US Food and Drug Administration's 'quality by design' approach is likely to transform the manufacture of biologics.
Anurag S, Rathore, Helen, Winkle
openaire   +2 more sources

Quality by Design

The TQM Magazine, 1990
Reveals how Nestle builds quality and safety into its products. Describes how the company employs a strict methodology to safeguard the quality and safety of its products. Reports on the Hazard Analysis Critical Control Point concept. Concludes that the final product still has to be checked because of government regulations.
openaire   +1 more source

Home - About - Disclaimer - Privacy